Cargando…
Alzheimer's Disease Diagnosis Using Misfolding Proteins in Blood
Alzheimer's disease (AD) is pathologically characterized by a long progressive phase of neuronal changes, including accumulation of extracellular amyloid-β (Aβ) and intracellular neurofibrillary tangles, before the onset of observable symptoms. Many efforts have been made to develop a blood-bas...
Autores principales: | Lee, HeeYang, Ugay, Daniella, Hong, Seungpyo, Kim, YoungSoo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Dementia Association
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7105719/ https://www.ncbi.nlm.nih.gov/pubmed/32174051 http://dx.doi.org/10.12779/dnd.2020.19.1.1 |
Ejemplares similares
-
Diagnosis of Alzheimer’s disease utilizing amyloid and tau as fluid biomarkers
por: Lee, Jinny Claire, et al.
Publicado: (2019) -
Physiological Roles of Monomeric Amyloid-β and Implications for Alzheimer’s Disease Therapeutics
por: Jeong, Hyomin, et al.
Publicado: (2022) -
Thioflavin-positive tau aggregates complicating quantification of amyloid plaques in the brain of 5XFAD transgenic mouse model
por: Shin, Jisu, et al.
Publicado: (2021) -
Carprofen alleviates Alzheimer-like phenotypes of 5XFAD transgenic mice by targeting the pathological hallmarks induced by amyloid-β aggregation
por: Lee, Donghee, et al.
Publicado: (2023) -
Solid-phase synthesis and pathological evaluation of pyroglutamate amyloid-β(3-42) peptide
por: Cho, Illhwan, et al.
Publicado: (2023)